[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100244176":3},{"organization":4,"armGroups":7,"interventions":44,"overallOfficials":67,"centralContacts":71,"locations":77,"responsibleParty":101,"collaborators":103,"id":109,"slug":110,"hasResults":111,"nctId":112,"briefTitle":113,"officialTitle":113,"acronym":114,"eligibilityCriteria":115,"healthyVolunteers":111,"sex":116,"minAge":117,"maxAge":118,"enrollmentInfo":119,"targetDuration":122,"studyType":123,"phases":10,"briefSummary":124,"conditions":125,"keywords":10,"overallStatus":80,"whyStopped":10,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":143},{"fullName":5,"class":6},"University Hospital, Ghent","OTHER",[8,14,19,24,29,34,39],{"label":9,"type":10,"description":11,"interventionNames":12},"amoxicillin-clavulanate",null,"Patients receiving amoxicillin-clavulanate as part of routine clinical care.",[13],"Procedure: blood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical care",{"label":15,"type":10,"description":16,"interventionNames":17},"piperacilline-tazobactam","Patients receiving piperacilline-tazobactam as part of routine clinical care.",[18],"Procedure: blood sampling in patients receiving piperacilline-tazobactam as part of routine clinical care.",{"label":20,"type":10,"description":21,"interventionNames":22},"vancomycin","Patients receiving vancomycin as part of routine clinical care.",[23],"Procedure: blood sampling in patients receiving vancomycin as part of routine clinical care.",{"label":25,"type":10,"description":26,"interventionNames":27},"teicoplanin","Patients receiving teicoplanin as part of routine clinical care.",[28],"Procedure: blood sampling in patients receiving teicoplanin as part of routine clinical care.",{"label":30,"type":10,"description":31,"interventionNames":32},"meropenem","Patients receiving meropenem as part of routine clinical care.",[33],"Procedure: blood sampling in patients receiving meropenem as part of routine clinical care.",{"label":35,"type":10,"description":36,"interventionNames":37},"ciprofloxacin","Patients receiving ciprofloxacin as part of routine clinical care.",[38],"Procedure: blood sampling and urine smapling in patients receiving ciprofloxacin as part of routine clinical care.",{"label":40,"type":10,"description":41,"interventionNames":42},"amikacin","Patients receiving amikcain as part of routine clinical care.",[43],"Procedure: blood sampling in patients receiving amikacin as part of routine clinical care.",[45,49,52,55,58,61,64],{"type":46,"name":47,"description":10,"armGroupLabels":48,"otherNames":10},"PROCEDURE","blood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical care",[9],{"type":46,"name":50,"description":10,"armGroupLabels":51,"otherNames":10},"blood sampling in patients receiving piperacilline-tazobactam as part of routine clinical care.",[15],{"type":46,"name":53,"description":10,"armGroupLabels":54,"otherNames":10},"blood sampling in patients receiving vancomycin as part of routine clinical care.",[20],{"type":46,"name":56,"description":10,"armGroupLabels":57,"otherNames":10},"blood sampling in patients receiving teicoplanin as part of routine clinical care.",[25],{"type":46,"name":59,"description":10,"armGroupLabels":60,"otherNames":10},"blood sampling in patients receiving meropenem as part of routine clinical care.",[30],{"type":46,"name":62,"description":10,"armGroupLabels":63,"otherNames":10},"blood sampling and urine smapling in patients receiving ciprofloxacin as part of routine clinical care.",[35],{"type":46,"name":65,"description":10,"armGroupLabels":66,"otherNames":10},"blood sampling in patients receiving amikacin as part of routine clinical care.",[40],[68],{"name":69,"affiliation":5,"role":70},"Pieter De Cock","PRINCIPAL_INVESTIGATOR",[72],{"name":73,"role":74,"phone":75,"phoneExt":10,"email":76},"Pieter De Cock, PharmD","CONTACT","+32 9 332 29 69","pieter.decock@uzgent.be",[78],{"facility":79,"status":80,"city":81,"state":10,"zip":82,"country":83,"countryCode":84,"cosmosGeoPoint":85,"geoPoint":90,"contacts":91},"Ghent University Hospital, Hospital Pharmacy","RECRUITING","Ghent","9000","Belgium","BE",{"type":86,"coordinates":87},"Point",[88,89],3.71667,51.05,{"lat":89,"lon":88},[92,94,95,97,99],{"name":73,"role":74,"phone":93,"phoneExt":10,"email":76},"+3293322969",{"name":73,"role":70,"phone":10,"phoneExt":10,"email":10},{"name":96,"role":70,"phone":10,"phoneExt":10,"email":10},"Annick de Jaeger, MD",{"name":98,"role":70,"phone":10,"phoneExt":10,"email":10},"Dominique Biarent, MD",{"name":100,"role":70,"phone":10,"phoneExt":10,"email":10},"Jozef De Dooy, MD",{"type":102,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[104,106],{"name":105,"class":6},"University Hospital, Antwerp",{"name":107,"class":108},"Queen Fabiola Children's University Hospital (HUDERF\u002FUKZKF)","UNKNOWN","100244176","antibiotic-dosing-in-pediatric-intensive-care-100244176",false,"NCT02456974","Antibiotic Dosing in Pediatric Intensive Care","ADIC","Inclusion Criteria:\n\n* patients admitted to the pediatric intensive care unit\n* patient age\u002Fweight : 1,8 kg-15 years\n* patient receiving antibiotic treatment (piperacillin-tazobactam, amoxicillin-clavulanate, vancomycin, teicoplanin, meropenem, ciprofloxacin, amikacin) via intermittent infusion regimen or continuous infusion according to institutional treatment guidelines\n* intra-arterial or intravenous access other than the drug infusion line available for blood sampling (arterial line is preferred)\n\nExclusion Criteria:\n\n* no catheter in place for blood sampling\n* absence of parental\u002Fpatient consent\n* known hypersensitivity to beta-lactam antibiotics, glycopeptides, fluoroquinolones, aminoglycosides\n* extracorporeal circuit (haemodialysis, ECMO, peritoneal dialysis )","ALL","1 Day","16 Years",{"count":120,"type":121},640,"ESTIMATED","3 Days","OBSERVATIONAL","Pharmacokinetics of antibiotics in critically ill neonates, infants and children",[126,127,128,129,130,131,132,133],"Pharmacokinetics","Amoxicillin-clavulanate","Piperacillin-tazobactam","Vancomycin","Teicoplanin","Meropenem","Ciprofloxacin","Amikacin","2026-01-15",{"date":136,"type":137},"2026-01-16","ACTUAL",{"date":139,"type":10},"2012-05",{"date":141,"type":121},"2027-09-01",{"name":5,"class":6},1]